Search

Search Constraints

You searched for: Author/Creator Lara, Primo N.

Search Results

11. Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy. Issue 21 (9th August 2019)

12. NCI 8628: A randomized phase 2 study of ziv‐aflibercept and high‐dose interleukin 2 or high‐dose interleukin 2 alone for inoperable stage III or IV melanoma. Issue 22 (10th October 2018)

14. Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non–Small-Cell Lung Cancer. (2021)

15. Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET‐Positive Non‐Small‐Cell Lung Cancer. (December 2021)

16. Prognostic Factors in De Novo Metastatic Renal Cell Carcinoma: A Report From the Latin American Renal Cancer Group. (2021)

18. Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984. Issue 4 (1st February 2023)

19. Relevance of Platinum-Sensitivity Status in Relapsed/Refractory Extensive-Stage Small-Cell Lung Cancer in the Modern Era. Issue 1 (January 2015)

20. Relevance of Platinum-Sensitivity Status in Relapsed/Refractory Extensive-Stage Small-Cell Lung Cancer in the Modern Era: A Patient-Level Analysis of Southwest Oncology Group Trials. Issue 1 (January 2015)